Valuation: CONMED Corporation

Market Cap 1.41B 1.27B 1.17B 1.06B 1.99B 134B 2.01B 14.05B 5.58B 70.38B 5.31B 5.19B 223B P/E 2026 *
12.2x
P/E 2027 * 10.5x
Enterprise Value 2.16B 1.93B 1.79B 1.62B 3.03B 205B 3.06B 21.41B 8.5B 107B 8.09B 7.92B 340B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.43x
Free-Float
95.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.01%
1 week-0.80%
Current month+2.10%
1 month+4.01%
3 months+8.48%
6 months+24.64%
Current year+16.26%
1 week 46.53
Extreme 46.53
49.73
1 month 43.97
Extreme 43.97
49.73
Current year 31.44
Extreme 31.44
53.66
1 year 31.44
Extreme 31.44
53.66
3 years 31.44
Extreme 31.44
117.27
5 years 31.44
Extreme 31.44
159.11
10 years 31.44
Extreme 31.44
159.11
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2025
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer 50 01/01/2025
Director TitleAgeSince
Director/Board Member 74 23/07/2014
Director/Board Member 60 01/01/2025
Director/Board Member 72 01/07/2015
Date Insider Type Main position Quantity % Market Cap. Importance
8/9/26 Exercice

Director

1,000 0.0033%
15/7/26 Other

Chief Financial Officer

0 0%
15/7/26 Free

Chief Financial Officer

92,465 0.3071%
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-0.80%-0.34%-50.29% 1.41B
-1.70%+0.63%-18.93%+11.04% 178B
-1.54%-0.98%-21.45%+15.09% 116B
-0.89%-0.72%-0.19%+35.32% 115B
-0.39%+4.34%-42.88%+7.77% 93.1B
-1.40%-5.21%-3.18%+73.40% 62.09B
+0.17%-0.34%+10.87%+84.40% 55.87B
-0.69%+0.63%+4.27%-22.48% 53.12B
-1.57%+0.60%-13.31%+43.41% 44.22B
-0.42%+2.29%-3.80%-9.44% 33.59B
Average -0.93%+1.97%-8.89%+18.82% 75.24B
Weighted average by Cap. -1.07%+2.36%-13.23%+24.07%

Financials

2026 *2027 *
Net sales 1.37B 1.23B 1.13B 1.03B 1.92B 130B 1.94B 13.58B 5.39B 68.04B 5.13B 5.02B 216B 1.43B 1.29B 1.19B 1.08B 2.01B 136B 2.04B 14.24B 5.66B 71.38B 5.38B 5.27B 226B
Net income 117M 105M 96.71M 87.7M 164M 11.08B 166M 1.16B 460M 5.81B 438M 429M 18.42B 135M 121M 112M 101M 190M 12.82B 192M 1.34B 533M 6.72B 507M 496M 21.31B
Net Debt 741M 665M 614M 557M 1.04B 70.43B 1.05B 7.37B 2.93B 36.92B 2.78B 2.72B 117B 638M 573M 529M 479M 896M 60.59B 907M 6.34B 2.52B 31.76B 2.39B 2.34B 101B
Projected Income Statement - Annual - CONMED Corporation
Logo CONMED Corporation
CONMED Corporation is a medical technology company which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product line consists of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Employees
3,900
Date Price Change Volume
27/10/26 US$47.20 -1.01% 505,947
26/10/26 US$47.68 -3.19% 386,605
23/10/26 US$49.25 -0.38% 343,264
22/10/26 US$49.44 +4.95% 398,583
21/10/26 US$47.11 -0.99% 442,963
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CONMED Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
47.20USD
Average target price
45.50USD
Spread / Average Target
-3.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CONMED Corporation
  1. Stock Market
  2. Stocks
  3. CNMD Stock